Section
Trials
New and updated registrations on ClinicalTrials.gov.
- Oct 30ClinicalTrials.gov
Tirzepatide and Organ-specific Biological Aging
By Priya Raman - Oct 30ClinicalTrials.gov
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
By Priya Raman - Oct 29ClinicalTrials.gov
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
By Priya Raman - Oct 29ClinicalTrials.gov
Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics
By Priya Raman - Oct 28ClinicalTrials.gov
Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity
By Priya Raman - Oct 28ClinicalTrials.gov
Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity
By Priya Raman - Oct 27ClinicalTrials.gov
Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
By Priya Raman - Oct 27ClinicalTrials.gov
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion
By Priya Raman - Oct 27ClinicalTrials.gov
SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
By Priya Raman - Oct 26ClinicalTrials.gov
Mayo Clinic registers Phase 4 tirzepatide reflux and gastric physiology study
By Priya Raman - Oct 26ClinicalTrials.gov
MUC1 peptide vaccine trial recruiting in non-small cell lung cancer
By Priya Raman - Oct 22ClinicalTrials.gov
Danish trial tests LEAP2 against ghrelin signaling during semaglutide treatment
By Priya Raman - Oct 22ClinicalTrials.gov
AstraZeneca starts Phase 3 trial of elecoglipron against oral semaglutide
By Priya Raman - Oct 22kalkine.ca
Arch Biopartners adds LSALT peptide trial sites in U.S. kidney injury program
By Priya Raman - Oct 21ClinicalTrials.gov
University of Florida opens phase 2 of GLP-1 plus levonorgestrel IUD in endometrial neoplasia
By Priya Raman - Oct 20ClinicalTrials.gov
University of Yaounde 1 plans Phase 2 trial of IGOB131 as GLP-1 modulator
By Priya Raman - Oct 20ClinicalTrials.gov
Structure Therapeutics starts Phase 3 aleniglipron trial in obesity with type 2 diabetes
By Priya Raman - Oct 20ClinicalTrials.gov
Pakistani cohort to track tirzepatide outcomes in 330 adults
By Priya Raman - Oct 20ClinicalTrials.gov
Arkansas terminates trial of residual gastric content in GLP-1 patients
By Priya Raman - Oct 20ClinicalTrials.gov
Munich trial tests resistance training against muscle loss on tirzepatide
By Priya Raman
- Oct 20ClinicalTrials.gov
Novartis registers real-world study of secukinumab retention with GLP-1 co-therapy
By Priya Raman BMJ reports US trial will test semaglutide's effect on criminal behaviour
By Priya Raman- Oct 19ClinicalTrials.gov
Lilly registers Phase 3 of eloralintide-tirzepatide coformulation in type 2 diabetes
By Priya Raman - Oct 19ClinicalTrials.gov
Washington University registers phase 3 trial of somatostatin analogues after PRRT
By Priya Raman - Oct 17Simply Wall Street
Viking starts SUNRISE Phase 3 program for oral VK2735 in obesity
By Priya Raman - Oct 16Bioengineer.org
Polish trial to test peptide P11-4 against fluoride varnish on enamel lesions
By Priya Raman - Oct 15ClinicalTrials.gov
Tufts registers trial of digital program for weight maintenance after GLP-1
By Priya Raman - Oct 15ClinicalTrials.gov
Fakih IVF registers thymosin alpha-1 trial in recurrent implantation failure
By Priya Raman - Oct 15ClinicalTrials.gov
Danish trial to test semaglutide effects on trained runners' performance
By Priya Raman - Oct 15BioXconomy
Axoltis peptide NX210c misses primary endpoints in Phase II ALS trial
By Priya Raman - Oct 14Fierce Biotech
Verdiva cancels GLP-1 switching trial, citing market evolution
By Priya Raman - Oct 14ClinicalTrials.gov
Structure Therapeutics completes phase 2 body composition trial of oral aleniglipron
By Priya Raman - Oct 14ClinicalTrials.gov
Boehringer recruiting for Phase III survodutide trial in MASH cirrhosis
By Priya Raman - Oct 14ClinicalTrials.gov
Toronto trial tests oral semaglutide against sitagliptin in liver transplant patients
By Priya Raman - Oct 13News-Medical
CASPR plans $13.3 million semaglutide trial in alcohol and opioid use disorder
By Priya Raman - Oct 13ClinicalTrials.gov
Canadian registry study tracks three-year semaglutide HbA1c outcomes
By Priya Raman - Oct 9ClinicalTrials.gov
Viking registers Phase 3 oral VK2735 trial in type 2 diabetes obesity
By Priya Raman - Oct 9ClinicalTrials.gov
Lilly recruiting Phase 2 of LY3457263 added to semaglutide or tirzepatide
By Priya Raman - Oct 9ClinicalTrials.gov
Novo Nordisk registers Phase 1 trial switching tirzepatide patients to zenagamtide
By Priya Raman
